Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Episyringaresinol 4'-O-β-D-glncopyranoside ((-)-Syringaresinol 4-O-β-D-glucopyranosi) inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 122.00 | |
10 mg | In stock | $ 197.00 | |
25 mg | In stock | Inquiry | |
50 mg | In stock | Inquiry | |
1 mL * 10 mM (in DMSO) | In stock | $ 163.00 |
Description | Episyringaresinol 4'-O-β-D-glncopyranoside ((-)-Syringaresinol 4-O-β-D-glucopyranosi) inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer. |
Source |
Synonyms | (-)-Syringaresinol 4-O-β-D-glucopyranosi |
Molecular Weight | 580.58 |
Formula | C28H36O13 |
CAS No. | 137038-13-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (86.12 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Episyringaresinol 4'-O-β-D-glncopyranoside 137038-13-2 Others Episyringaresinol 4'-O-b-D-glncopyranoside inhibit Syringaresinol 4-O-beta-D-glucopyranosi Syringaresinol 4-O-b-D-glucopyranosi Inhibitor Episyringaresinol 4'-O-beta-D-glncopyranoside Episyringaresinol 4'OβDglncopyranoside Episyringaresinol 4' O β D glncopyranoside (-)-Syringaresinol 4-O-β-D-glucopyranosi Syringaresinol 4-O-β-D-glucopyranosi inhibitor